Toxoplasmosis in Cats: Indoor Risk, Transmission, and Zoonotic Prevention

Etiology and Life Cycle of Toxoplasma gondii

Toxoplasmosis is a globally distributed zoonotic disease caused by the obligate intracellular apicomplexan protozoan Toxoplasma gondii [1, 2]. The parasite exists in three infectious stages: tachyzoites (rapidly dividing), bradyzoites (slowly dividing within tissue cysts), and sporozoites (within oocysts) [1]. Felids, including domestic cats (Felis catus), serve as the definitive hosts because they are the only species capable of shedding environmentally resistant oocysts in their feces [1, 3]. The sexual cycle of T. gondii occurs exclusively within the feline intestinal epithelium, leading to the production of unsporulated oocysts that are shed into the environment [1, 4]. Upon sporulation, which occurs within one to five days under aerobic conditions, oocysts become infectious to all warm-blooded intermediate hosts, including birds, livestock, and humans [1, 3].

Cats typically acquire infection through predation on infected intermediate hosts containing tissue cysts (bradyzoites) or through ingestion of sporulated oocysts from contaminated environments [1, 5]. Experimental studies have demonstrated that cats fed tissue cysts of T. gondii begin shedding oocysts within three to ten days post-infection, with peak shedding occurring during the first week [5, 6]. A single cat can excrete millions of oocysts over a period of one to three weeks, contributing substantially to environmental contamination [1, 3]. The prepatent period is shorter (3–10 days) following ingestion of bradyzoites compared to ingestion of oocysts (≥18 days) [1, 5].

Indoor Cat Toxoplasmosis Risk

The concept of indoor cat toxoplasmosis risk is frequently misunderstood by both pet owners and some veterinary practitioners. While indoor-only cats have a lower probability of exposure to T. gondii compared to free-roaming or semi-domesticated cats, they are not entirely free from risk [7, 8]. Several studies have documented seropositivity in strictly indoor cats, indicating that alternative transmission routes exist [7, 35]. In a study conducted in Greece, 20.8% of 457 cats were seropositive for T. gondii, and multivariate analysis identified older age, a history of cat-fight trauma, and lack of routine vaccination as significant risk factors [35]. Although cat-fight trauma is more common in outdoor cats, the finding underscores that behavioral and immunological factors modulate infection risk irrespective of housing status.

The primary sources of infection for indoor cats include the feeding of raw or undercooked meat, exposure to contaminated litter or soil brought indoors on shoes, and ingestion of sporulated oocysts from fomites [1, 34]. A study from Thailand reported a 1.5% seroprevalence in pet cats compared to 11.5% in semi-domesticated cats, confirming that confinement reduces but does not eliminate risk [7]. Similarly, a study in Pakistan found that stray cats had a significantly higher infection rate (74.6%) compared to pet cats (25.4%), with older cats (>4 years) showing the highest prevalence (91.66%) [8]. These data indicate that age-related cumulative exposure is a critical factor, and even indoor cats can become infected if management practices are suboptimal.

Transmission Pathways and Oocyst Shedding Dynamics

Transmission of T. gondii to cats occurs via three principal routes: (1) ingestion of tissue cysts in raw or undercooked meat, (2) ingestion of sporulated oocysts from contaminated environments, and (3) transplacental transmission, which is less common in cats than in some other species [1, 9]. Neonatal toxoplasmosis has been documented in kittens, with lesions including encephalitis, myocarditis, and pneumonitis [9]. In a retrospective study of 100 histologically confirmed cases, 9 cats had neonatal toxoplasmosis, and 14 had concurrent microbial infections [10].

Oocyst shedding is a transient phenomenon in cats, typically lasting one to three weeks following primary infection [1, 6]. However, re-shedding can occur upon re-infection, particularly in immunocompromised individuals [1]. The magnitude of oocyst output is influenced by the infective stage and dose. Cats fed tissue cysts shed significantly more oocysts than those fed oocysts [5]. Environmental factors such as temperature, humidity, and soil composition affect oocyst survival; sporulated oocysts can remain infectious for months to years in moist, shaded environments [1, 3].

The role of stray cats in environmental contamination is substantial. In a study from Izmir, Turkey, T. gondii DNA was detected in 14.37% of fecal samples from 465 stray cats, and the seroprevalence was 37.84% [11]. These findings highlight the potential for stray cat populations to serve as reservoirs for environmental oocyst contamination, posing a risk to both humans and other animals [11, 32]. In Sidoarjo, Indonesia, oocyst prevalence in stray cats from markets ranged from 12.5% to 37.5%, with higher prevalence associated with poor sanitation [32].

Clinical Signs and Pathological Manifestations

Clinical toxoplasmosis in cats is relatively uncommon despite high seroprevalence rates, which can exceed 37% in some populations [12, 11]. When disease does occur, it is often associated with immunosuppression, concurrent infections, or infection with particular genotypes [1, 10, 34]. The most common clinical presentations include respiratory distress (dyspnea, polypnea), fever, anorexia, lethargy, and abdominal discomfort [10, 2]. In a large case series of 100 histologically confirmed cases, 73% of cats had fever (40.0–41.7°C), and pulmonary lesions were the predominant finding in 26% of cases [10].

Neurological and ocular forms of toxoplasmosis are well documented [13, 10, 14, 2]. Neurological signs may include ataxia, seizures, circling, and behavioral changes, reflecting encephalomyelitis [13, 2]. Ocular toxoplasmosis manifests as uveitis, iridocyclochoroiditis, and retinitis [10, 14]. In the case series by Dubey and Carpenter, 81.5% of 27 cats examined histologically had evidence of intraocular inflammation, with the ciliary body being the most severely affected uveal structure [10]. T. gondii organisms were identified in the retina, choroid, optic nerve, iris, and ciliary body [10].

Cutaneous toxoplasmosis, though less common, has been reported and may present as nodular or ulcerative dermatitis [2]. The genotype of T. gondii can influence clinical outcome. For example, ToxoDB genotype #4, commonly found in wildlife, was associated with overwhelming disseminated toxoplasmosis in two littermate kittens that succumbed to acute primary infection [34]. In China, genotype #9 (Chinese 1) has been epidemiologically linked to clinical outbreaks in pigs and human deaths [1].

Diagnostic Approaches

Diagnosis of toxoplasmosis in cats relies on a combination of serological, molecular, and histopathological methods [15, 1, 30]. Serological tests detect anti-T. gondii antibodies, primarily IgG and IgM, using techniques such as enzyme-linked immunosorbent assay (ELISA), indirect immunofluorescence antibody test (IFAT), modified agglutination test (MAT), and immunochromatographic rapid test kits [15, 3, 6, 30]. The MAT using formalin-preserved tachyzoites has been shown to be more sensitive than tests using acetone-preserved tachyzoites or other methods [6]. In a comparative study, recombinant GRA7 demonstrated higher sensitivity than SAG2 and GRA6 for serodiagnosis in cats [30].

Rapid diagnostic test kits are increasingly used in clinical settings due to their ease of use, cost-effectiveness, and rapid turnaround time [15]. In a study of 50 cats in Turkey, immunochromatographic rapid tests detected a 6% prevalence of toxoplasmosis [15]. However, these tests may have lower sensitivity compared to ELISA or IFAT, and confirmatory testing is recommended [15, 3]. In Brazil, ELISA detected 15.2% seroprevalence compared to 7.6% by IFAT, with moderate agreement between the two tests (kappa = 0.63) [3].

Molecular diagnostics, particularly polymerase chain reaction (PCR), are used to detect T. gondii DNA in blood, feces, cerebrospinal fluid, and tissue samples [8, 11, 30]. Real-time PCR assays offer high sensitivity and specificity for detecting oocysts in fecal samples [11]. In Pakistan, PCR detected T. gondii DNA in 74.6% of stray cats and 25.4% of pet cats, with chronic or reactivated chronic infection (58.37%) more common than acute infection [8].

Histopathological examination with immunohistochemical staining remains the gold standard for definitive diagnosis, particularly in postmortem cases [10, 9]. In the 100-case series, T. gondii was identified in 80% of brains, 76.7% of lungs, 70% of livers, and 62.7% of hearts [10]. Cytological evaluation of tracheal aspirates, pleural fluid, and biopsy specimens can also reveal tachyzoites in antemortem samples [10].

The following table summarizes the principal diagnostic methods and their characteristics:

Treatment and Therapeutic Considerations

Treatment of clinical toxoplasmosis in cats is indicated when signs are present, particularly in cases of ocular, neurological, or respiratory involvement [16, 2, 17]. The primary therapeutic agent is clindamycin, administered at a dosage of 10–12 mg/kg orally every 12 hours for 2–4 weeks [16, 2]. Clindamycin is effective against tachyzoites but does not eliminate tissue cysts [16]. In experimental acute toxoplasmosis, clindamycin reduced clinical signs but did not prevent oocyst shedding [16]. A paradoxical effect has been observed, where clindamycin treatment was associated with increased mortality in some experimental settings, possibly due to rapid lysis of organisms and subsequent inflammatory responses [16].

Alternative treatments include trimethoprim-sulfonamide combinations, azithromycin, and pyrimethamine combined with sulfadiazine [2, 17]. However, these are less commonly used in cats due to potential adverse effects. In Pallas' cats (Otocolobus manul), prophylactic clindamycin administered during key exposure periods reduced first-year mortality from toxoplasmosis by 67% [33]. This protocol is relevant for captive management of susceptible felid species.

Supportive care, including fluid therapy, nutritional support, and management of secondary infections, is critical in severe cases [2]. Corticosteroids are contraindicated in active toxoplasmosis due to the risk of exacerbating infection [2].

Zoonotic Prevention and Control Strategies

Prevention of zoonotic transmission from cats to humans requires a multifaceted approach targeting oocyst contamination and direct contact with infected feces [1, 17, 31]. The primary preventive measures include:

• Daily cleaning of litter boxes, as oocysts require 1–5 days to sporulate and become infectious [1, 17].
• Disposal of cat feces in sealed bags, avoiding disposal in gardens or compost heaps [17].
• Wearing gloves and washing hands thoroughly after handling litter boxes or gardening in areas accessible to cats [31].
• Feeding cats only commercially processed or thoroughly cooked food, avoiding raw meat diets [1, 34].
• Keeping cats indoors to reduce predation and exposure to infected intermediate hosts [7, 35].
• Covering children's sandboxes when not in use to prevent fecal contamination [17].

Public health education is essential, as many cat owners are unaware of toxoplasmosis transmission risks [31]. In a study from Unguja Island, Tanzania, only 18% of respondents were aware of toxoplasmosis, and 63.1% did not deworm their cats regularly [31]. Knowledge of the disease was associated with higher education levels and female sex [31].

The following Mermaid diagram illustrates the decision framework for managing toxoplasmosis risk in indoor cats:

flowchart TD
    A[Indoor Cat Presentation], > B{Risk Assessment}
    B, >|Raw diet or outdoor access| C[High Risk]
    B, >|Commercial diet, strictly indoor| D[Low Risk]
    C, > E[Serological Screening]
    D, > F[Annual Wellness Check]
    E, > G{Seropositive?}
    G, >|Yes| H[Clinical Signs Present?]
    G, >|No| I[Continue Prevention]
    H, >|Yes| J[Initiate Clindamycin Therapy]
    H, >|No| K[Monitor, No Treatment]
    J, > L[Follow-up Serology/PCR]
    K, > M[Reinforce Hygiene Protocols]
    I, > M
    L, > N[Resolution or Relapse?]
    N, >|Resolution| M
    N, >|Relapse| J

Epidemiological Considerations and Public Health Implications

The seroprevalence of T. gondii in domestic cat populations varies widely by geographic region, management practices, and diagnostic methods [1, 3, 18, 19, 20, 21, 7, 12, 8, 11, 35]. In Egypt, a high prevalence of viable T. gondii was isolated from cats, with tissue distribution including brain, heart, and skeletal muscle [20]. In Brazil, seroprevalence ranged from 7.6% to 15.2% depending on the test used [3], while in northeastern Brazil, co-infection with Neospora caninum, feline immunodeficiency virus (FIV), and feline leukemia virus (FeLV) was documented [18]. In Pakistan, seroprevalence was 74.6% in stray cats [8], and in Slovakia, 37.4% of 441 cats were seropositive [12].

Cats serve as sentinel species for human toxoplasmosis risk, as their seroprevalence reflects environmental oocyst contamination [12]. The presence of T. gondii DNA in feces of stray cats (14.37% in Turkey) indicates ongoing environmental contamination [11]. Mathematical models of toxoplasmosis transmission in human and cat populations emphasize the importance of controlling oocyst shedding to reduce human infection [22].

Genotyping of T. gondii isolates from cats has revealed significant genetic diversity, with certain genotypes associated with clinical disease in humans and animals [1, 34]. The Chinese 1 genotype (ToxoDB #9) is prevalent in cats in China and has been linked to human outbreaks [1]. In the United States, genotype #4, commonly found in wildlife, caused fatal disseminated toxoplasmosis in kittens [34]. These findings underscore the need for continued surveillance and genotyping to understand regional transmission dynamics.

Conclusion

Toxoplasmosis in cats remains a significant veterinary and public health concern. Indoor cats are at lower but not negligible risk of infection, with raw meat feeding and environmental contamination representing key transmission routes. Accurate diagnosis requires a combination of serological and molecular methods, and treatment with clindamycin is effective for clinical cases. Zoonotic prevention hinges on proper litter box hygiene, feeding practices, and public education. Ongoing surveillance, including genotyping of circulating strains, is essential for informing control strategies and mitigating the risk of human infection.

References

[1] Dubey, J., Cerqueira-Cézar, C. K., Murata, F., et al. (2020). All about toxoplasmosis in cats: the last decade. Veterinary Parasitology. https://www.semanticscholar.org/paper/f0acbbba7cd9f8c048d5d0764bbf9a13fc7c158b

[2] Calero-Bernal, R., & Gennari, S. (2019). Clinical Toxoplasmosis in Dogs and Cats: An Update. Frontiers in Veterinary Science. https://www.semanticscholar.org/paper/85289202e785e3bc73f8f5115e9316d859714c0c

[3] Fux, B., Covre, K., Lopes, R., et al. (2020). Seroprevalence of Toxoplasmosis in Cats in Espirito Santo State, Brazil. Current Developments in Nutrition. https://www.semanticscholar.org/paper/c8a06a7c2da069a70425a4ee3b10947240fb5aca

[4] Dubey, J. (1986). Toxoplasmosis in cats. Journal. https://www.semanticscholar.org/paper/2d40c71cd859696150a18a7a02da5c18e19cb9f6

[5] Dubey, J., & Frenkel, J. K. (1972). Cyst-induced toxoplasmosis in cats. The Journal of Protozoology. https://www.semanticscholar.org/paper/12d02c2160648955e5516f3c6df5f8ca6fc8d0c9

[6] Dubey, J., & Thulliez, P. (1989). Serologic diagnosis of toxoplasmosis in cats fed Toxoplasma gondii tissue cysts. Journal of the American Veterinary Medical Association. https://www.semanticscholar.org/paper/ee22536cb0d9e4d5bd35bdcff522943c207f2843

[7] Inpankaew, T., Sattasathuchana, P., Kengradomkij, C., et al. (2021). Prevalence of toxoplasmosis in semi-domesticated and pet cats within and around Bangkok, Thailand. BMC Veterinary Research. https://www.semanticscholar.org/paper/9d019b6566281c83eacd73785646da54fbe4f464

[8] Majid, A., Ahmad, N., Haleem, S., et al. (2021). Detection of toxoplasmosis in pets and stray cats through molecular and serological techniques in Khyber Pakhtunkhwa, Pakistan. BMC Veterinary Research. https://www.semanticscholar.org/paper/8d881c294db66470f8cb1039711b82f9beddee6c

[9] Dubey, J., Mattix, M., & Lipscomb, T. (1996). Lesions of Neonatally Induced Toxoplasmosis in Cats. Veterinary Pathology-Supplement. https://www.semanticscholar.org/paper/1254e6ad6e3a8af547409537637842df2c9baaf2

[10] Dubey, J., & Carpenter, J. (1993). Histologically confirmed clinical toxoplasmosis in cats: 100 cases (1952-1990). Journal of the American Veterinary Medical Association. https://www.semanticscholar.org/paper/d52209abc2a6337a4c9d08f712a537010200385e

[11] Karakavuk, M., Can, H., Selim, N., et al. (2021). Investigation of the role of stray cats for transmission of toxoplasmosis to humans and animals living in İzmir, Turkey. Journal of Infection in Developing Countries. https://www.semanticscholar.org/paper/d4034b4469c570f968226bd0f2428a8841127668

[12] Selyemová, D., Antolová, D., Mangová, B., et al. (2024). Cats as a sentinel species for human infectious diseases – toxoplasmosis, trichinellosis, and COVID-19. Current Research in Parasitology and Vector-Borne Diseases. https://www.semanticscholar.org/paper/ce0b02c41d9424f9078cf916d5152566094d337a

[13] Cucoș, C., Ionașcu, I., Mocanu, J., et al. (2015). Neurological and ocular form of toxoplasmosis in cats. Journal. https://www.semanticscholar.org/paper/aa122640585a7963211031f376cc4dfc5aad4bb2

[14] Vainisi, S. J., & Campbell, L. H. (1969). Ocular toxoplasmosis in cats. Journal. https://www.semanticscholar.org/paper/249b39e2a160380e0392f576ba6c852d4525e72d

[15] Parlatır, Y., Şenel, Y., & Kara, E. (2025). Determination of the Prevalance of Toxoplasmosis in Cats with Immunochoromatographic Rapid Tests Kits in Kırıkkale University Veterinary Faculty Animal Hospital. Research and Practice in Veterinary and Animal Science. https://www.semanticscholar.org/paper/247f3db5fd827af96d636da4d3164d751074874f

[16] Davidson, M. G., Lappin, M., Rottman, J. R., et al. (1996). Paradoxical effect of clindamycin in experimental, acute toxoplasmosis in cats. Antimicrobial Agents and Chemotherapy. https://www.semanticscholar.org/paper/3c33146daf33215dac6e658719c1d07bb266fdf7

[17] Frenkel, J. K. (1978). Toxoplasmosis in cats: diagnosis, treatment and prevention. Comparative Immunology, Microbiology & Infectious Diseases. https://www.semanticscholar.org/paper/83342586a02084c5abca00f2f74a7c8eaed91493

[18] Munhoz, A., Hage, S. B., Cruz, R., et al. (2017). Toxoplasmosis in cats in northeastern Brazil: Frequency, associated factors and coinfection with Neospora caninum, feline immunodeficiency virus and feline leukemia virus. Veterinary Parasitology: Regional Studies and Reports. https://www.semanticscholar.org/paper/7c8a2fdd2e9561c2569bc4e98397bbe347e630a2

[19] Ahmad, N., Ahmed, H., Irum, S., et al. (2014). Seroprevalence of IgG and IgM antibodies and associated risk factors for toxoplasmosis in cats and dogs from sub-tropical arid parts of Pakistan. Tropical Biomedicine. https://www.semanticscholar.org/paper/da6e18e25d3ce94af78a72a188b4814bde5a4bf6

[20] Al-kappany, Y., Rajendran, C., Ferreira, L. R., et al. (2010). High Prevalence of Toxoplasmosis in Cats from Egypt: Isolation of Viable Toxoplasma gondii, Tissue Distribution, and Isolate Designation. Journal of Parasitology. https://www.semanticscholar.org/paper/eb0cb3755cb9a332123f4cff955b60832811f357

[21] Shahzad, A., Khan, M. S., Ashraf, K., et al. (2006). Sero-epidemiological and haematological studies on toxoplasmosis in cats, dogs and their owners in Lahore, Pakistan. Journal. https://www.semanticscholar.org/paper/7d0dfdee60bdf59fcc72a83a2c3ef69c3c975815

[22] Zafar, Z., Ali, N., & Baleanu, D. (2021). Dynamics and numerical investigations of a fractional-order model of toxoplasmosis in the population of human and cats. Journal. https://www.semanticscholar.org/paper/db91c7fb65e1a1d56be21460221b7855e2809a5c

[23] Shen, Y., Zheng, B., Sun, H., et al. (2023). A live attenuated RHΔompdcΔuprt mutant of Toxoplasma gondii induces strong protective immunity against toxoplasmosis in mice and cats. Infectious Diseases of Poverty. https://www.semanticscholar.org/paper/2c0eccd9ce92a1acbb4617baa6621f2d56e59c5e

[24] Dubey, J. P., Hoover, E., & Walls, K. (1977). Effect of age and sex on the acquisition of immunity to toxoplasmosis in cats. The Journal of Protozoology. https://www.semanticscholar.org/paper/23dc34fe496f694a558cf945c5ed25693529c1dd

[25] Germano, P. M., Melo, H., Bianchin, I., et al. (1980). Toxoplasmosis in cats and dogs. Journal. https://www.semanticscholar.org/paper/28ba5dd1a8560109667f0cde4939e26be92466a8

[26] Bastan, I. (2018). Clinical and some laboratory findings in cats with Toxoplasmosis. Journal. https://www.semanticscholar.org/paper/22a23aba5dc5ed1ccad8996586a2a1622e64a857

[27] Vinogradov, L. I. (1980). Diagnosis of toxoplasmosis in cats. Journal. https://www.semanticscholar.org/paper/547f904162fe1e9133e7b8fbdd7c56c7fd520f18

[28] Dubey, J. P., Lehmann, T., Lautner, F., et al. (2015). Toxoplasmosis in sentinel chickens (Gallus domesticus) in New England farms: Seroconversion, distribution of tissue cysts in brain, heart, and skeletal muscle by bioassay in mice and cats. Veterinary Parasitology. https://www.semanticscholar.org/paper/42d3ddc4b9f40d6e02a8ef8aaaa90